Institutional Review Board & Ethics Committee

Latest News

October 31st 2025

Engineered Bispecific Antibodies: Regulatory, Ethical, and Best Practice Guidelines

By Sharad Adekar, MD, PhD, CIP, Currien MacDonald

Ethical and regulatory considerations for safeguarding participants in bispecific antibody clinical trials, and best practices designed to optimize their success.

July 8th 2025

Obsolete Trial Marketing Guidelines and Missing Processes Hurt Patient Enrollment

By Christine Senn, PhD, FACRP

© putilov_denis - © putilov_denis - stock.adobe.com

May 12th 2025

3 Common eCOA Implementation Challenges and How to Solve Them

By Chase Carmeans

© photon_photo - © photon_photo - stock.adobe.com.

April 28th 2025

The Latest Advancements in Single Sign-On Technology

By Stuart Cotter

Institutional Review Board & Ethics Committee

Latest News

Latest Videos

Empowering Clinicians to Communicate Clinical Trial Opportunities Effectively

More News

Trending on Applied Clinical Trials Online

ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle

ACT Brief: ICON-Microsoft AI Partnership, DCT Site Burden, and AI-Enabled Neuroimmune Discovery

ACT Brief: Mixed FSP Strategy, DIA Meeting Trends, and Patient Voice in Oncology

HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research

ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility